Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10067 |
| Vaccine Name | KCONVAC |
| Disease Name | COVID-19 |
| Disease Classification | Respiratory |
| Virus Name | SARS-CoV-2 virus |
| Nucleic Acid Content | positive-sense, single-stranded RNA |
| Vaccine Type | Inactivated |
| Vaccine Status | Approved |
| Manufacturer | Shenzhen Kangtai Biological Products Co. Ltd |
| Year of Manufacturing | 2021 |
| Manufacturing Country | China |
| Age | 18 years and above |
| Dosage | 2 doses 28 days apart |
| Administration Route | Intramuscular |
| Adjuvant | NA |
| Target Strain | NA |
| Description | NA |
| Approving Organisation | China FDA |
| Collaborating Organisation | Beijing Minhai Biotechnology Co. |
| Other Countries | China, Indonesia |
| Trade Name | NA |
| PMID | NA |
| Clinical Trial ID | NCT05204589 |
| Reference Link | https://clinicaltrials.gov/ct2/show/NCT05204589 |
| Additional Links | https://www.reuters.com/article/us-health-coronavirus-vaccine-kangtai/kangtai-biologicals-covid-19-vaccine-gets-emergency-use-approval-in-china-idUSKBN2CV1F6 |